BRIEF-Celyad announces approval to initiate NKR-2 CAR-T in Belgium

* Celyad announces the approval to initiate its NKR-2 CAR-T clinical trial in Belgium

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more